This is a very good company fundamentally and is very much renowned abroad as well. This the reason it had earlier issued FCCB abroad successfully. Its stronghold in healthcare, financials like credit cards, etc and insurance. All these 3 verticals are bound to do good in long term. I dont see any reason to panic. I am certain it will cross 40+ this time after it reaches 33 in this technical correction. Hence buy then to book hefty profits in dec end or jan first week. Cheers!!!
Decision varies from person to person. You take a call....
| NIFTY 
